Table 1 Baseline characteristics of training and validation sets.

From: Development and validation of a nomogram model for individualized prediction of hypertension risk in patients with type 2 diabetes mellitus

Characteristic

Training set (n = 521)

Validation set (n = 185)

P-value

Age [years]

56.84 ± 12.38

54.56 ± 11.13

0.021

Gender (n, %)

 Male

317 (60.8)

121 (65.4)

0.313

 Female

204 (39.2)

64 (35.6)

Duration of diabetes [years]

8.76 ± 7.29

8.81 ± 7.30

0.945

BMI [kg/m2]

26.02 ± 4.62

26.06 ± 3.54

0.909

Hypertension (n, %)

 Yes

300 (57.6)

102 (55.1)

0.624

 No

221 (42.4)

83 (44.9)

Diabetes complications

 DN (n, %)

  Yes

133 (34.3)

62 (33.5)

0.046

  No

388 (65.7)

123 (66.5)

 DPN (n, %)

  Yes

298 (57.2)

116 (62.7)

0.223

  No

223 (42.8)

69 (37.3)

 DR (n, %)

  Yes

313 (60.1)

125 (67.6)

0.778

  No

208 (39.9)

60 (22.4)

Lifestyle habits

 Smoking (n, %)

  Never

354 (67.9)

114 (61.6)

0.141

  Ever/current

167 (32.1)

71 (38.4)

 Consuming alcohol (n, %)

  Never

364 (69.9)

122 (65.9)

0.37

  Ever/current

157 (30.1)

63 (34.1)

Biochemical tests result in characteristics

FBG [mmol/L]

7.93 ± 2.67

7.15 ± 2.13

 < 0.001

2H-OGTT [mmol/L]

16.69 ± 4.48

16.55 ± 11.06

0.868

HbA1c [%]

8.75 ± 2.21

8.71 ± 1.88

0.833

eGFR [ml/min/1.73 m2]

94.13 ± 21.08

96.08 ± 22.26

0.300

Scr [μ mol/L]

71.74 ± 24.94

70.28 ± 23.97

0.491

TG [mmol/L]

2.15 ± 1.97

2.10 ± 2.03

0.777

HDL-C [mmol/L]

0.98 ± 0.27

0.99 ± 0.35

0.489